In conclusion, our results indicate BCAA metabolism is involved in NAFLD and BCATc Inhibitor 2 protects against oleic acid-induced lipid accumulation and apoptosis. This evidence concerns the gene BCAT1 and metabolic dysfunction-associated steatotic liver disease.